Published by Josh White on 25th October 2024
(Sharecast News) - Sanofi reported stronger-than-expected third-quarter earnings on Friday, driven by early vaccine sales and robust performance from its anti-inflammatory drug Dupixent.
URL: http://www.digitallook.com/dl/news/story/34648904/...